Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder (Q44724351)

5 December 2017

title

Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder (English)

1 reference

5 December 2017

3

1 reference

5 December 2017

4

1 reference

5 December 2017

Alessandro Serretti

9

0 references

author name string

Alberto Chiesa

1

1 reference

5 December 2017

Concetta Crisafulli

2

1 reference

5 December 2017

Ashwin A Patkar

5

1 reference

5 December 2017

Soo-Jung Lee

6

1 reference

5 December 2017

Moon Ho Park

7

1 reference

5 December 2017

Tae-Youn Jun

8

1 reference

5 December 2017

Chi-Un Pae

10

1 reference

5 December 2017

publication date

5 November 2011

1 reference

European Archives of Psychiatry and Clinical Neuroscience

5 December 2017

published in

1 reference

5 December 2017

volume

262

1 reference

5 December 2017

issue

4

1 reference

5 December 2017

page(s)

305-311

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-011-0270-y

5 December 2017

exact match

0 references

cites work

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

The role of proteomics in depression research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

A family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

AMPA receptors in the therapeutic management of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Restoration of spatial working memory by genetic rescue of GluR-A-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Evidence of susceptibility loci on 4q32 and 16p12 for bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Depressive symptoms in acute schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Malignancy of recurrent, early-onset major depression: a family study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Spurious genetic associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0270-Y

Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons.

21 January 2018

1 reference

12 December 2020

Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression.

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

1 reference

12 December 2020

Response and remission criteria in major depression--a validation of current practice

1 reference

12 December 2020

Immunochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies. Evidence for a hetero-oligomeric structure in rat brain

1 reference

12 December 2020

Schizophrenia as a disorder of disconnectivity

1 reference

12 December 2020

10.1007/S00406-011-0270-Y

Identifiers

DOI

1 reference

5 December 2017

1 reference